유럽 ​​멀티플렉스 분석 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 유럽 멀티플렉스 분석 시장

Data Bridge Market Research에 따르면 유럽 멀티플렉스 검사 시장이 2021~2028년 예측 기간 동안 8.87%의 CAGR로 성장할 것으로 분석됩니다.

멀티플렉스 분석은 자기 또는 비자성 비드를 사용하여 단일 샘플에서 여러 분석 항목을 결정하는 면역 분석입니다. 멀티플렉스 분석은 ELISA 와 동일 하지만 멀티플렉스 분석에서 포획 항체를 결합하는 데 비드를 사용합니다. 멀티플렉스 분석은 장점으로 인해 임상 환경보다 연구에서 점점 더 흔해지고 있습니다.

만성 질환, 주로 암 의 증가 와 동반 진단에서 멀티플렉스 검사의 사용 증가는 멀티플렉스 검사 시장 성장에 영향을 미치는 주요 요인입니다. 또한, 싱글플렉스 및 기존 검사에 비해 멀티플렉스 검사의 이점, 기술 발전, 증가하는 의료비 지출, 다양한 질병 및 병리적 상태의 다인자적 특성에 대한 인식 증가는 멀티플렉스 검사 시장 성장을 강화할 주요 촉진 요인입니다.

분자 및 단백질 진단에서 바이오마커 검증의 증가와 고처리량 및 자동화 시스템에 대한 필요성은 시장 성장을 위한 유익한 기회를 창출할 것입니다.

그러나 장비와 관련된 높은 비용과 숙련된 노동력의 부족은 시장 성장을 방해하는 요인입니다. 엄격한 규제와 표준은 멀티플렉스 분석 시장에 도전할 것입니다.

This Europe multiplex assays market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Europe multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Europe Multiplex Assays Market Scope and Market Size

The Europe multiplex assays market is segmented on the basis of product and services, type, technology, application and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• The multiplex assays market is segmented on the basis of products and services into reagents and consumables, instruments and accessories, and software and services.
• On the basis of type, the multiplex assays market is segmented into nucleic acid multiplex assays, protein multiplex assays, and cell-based multiplex assays. Protein multiplex assays have been further sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays have been further sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays.
• On the basis of technology, the multiplex assays market is segmented into protein microarray, polymerase chain reaction, multiplex real-time PCR, flow cytometry, fluorescence detection, luminescence and others.
• On the basis of application, the multiplex assays market is segmented into clinical diagnostics, research and development. Clinical diagnostics have been further sub-segmented into cancer, autoimmune diseases, infectious diseases, nervous system disorders, infectious diseases, allergies, metabolism and endocrinology disorders, cardiovascular diseases, and others. Research and development has been further sub-segmented into drug discovery and development and biomarker discovery and validation.
• On the basis of end-users, the multiplex assays market is segmented into hospital, clinical laboratories, pharmaceutical and biotechnology companies, research institutes and others.

Europe Multiplex Assays Market Country Level Analysis

The Europe multiplex assays market is analysed and market size insights and trends are provided by country, product and services, type, technology, application and end-users as referenced above.

The countries covered in Europe multiplex assays market report are Germany, France, the U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe.

The United Kingdom dominates the Europe multiplex assays market and will continue to flourish its trend of dominance during the forecast period due to the well-established healthcare sector and growing government initiatives to facilitate genomic and clinical research in this region. France will however, register the highest CAGR for this period due to the development in genome sector and rise in the number of programs involved with development of multiplex assays and clinical trials.

The country section of the Europe multiplex assays market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The Europe multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe multiplex assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe multiplex assays market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Europe Multiplex Assays Market Share Analysis

The Europe multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Europe multiplex assays market.

유럽 ​​멀티플렉스 검사 시장 보고서에 포함된 주요 기업으로는 BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens, Agena Bioscience, Inc., Hologic Inc., Luminex Corporation., MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc., Illumina, Inc., Olink, Agilent Technologies, Inc., Randox Laboratories Ltd., Bio-Techne., Sysmex Corporation 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-27501